Diphenylterazine (DTZ) is a bioluminescence agent. Diphenylterazine alone yielded very little background, leading to excellent signal-to-background ratios.
性状
Solid
体外研究(In Vitro)
Diphenylterazine elicits minimal cell toxicity at millimolar concentrations.Notes: To make a stock solution for DTZ (Diphenylterazine), first, a premixture is prepared by dissolving 17.6 mg of L-ascorbic acid (HY-B0166) in 10 mL ethanol and 10 mL 1,2-propanediol; next, 1 mg of DTZ is dissolved in 88 μL of the premix, resulting in a 30 mM DTZ stock solution containing 5 mM L-ascorbic acid. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Diphenylterazine injections into untransfected BALB/c mice do not yield any background emission. The bioluminescence resulting from intraperitoneally injected Diphenylterazine displays extended kinetics.
DTZ (0.3 μmol/mouse (1.13 mg.ml/100 ul/mouse); i.v.) treatment can track tumor growth in a xenograft NU/J mouse model. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
-80°C, protect from light, stored under nitrogen
参考文献
[1]. Yeh HW, et al. Red-shifted luciferase-luciferin pairs for enhanced bioluminescence imaging. Nat Methods. 2017 Oct;14(10):971-974.[2]. Hsien-Wei Yeh, et al. ATP-Independent Bioluminescent Reporter Variants To Improve in Vivo Imaging. ACS Chem Biol. 2019 May 17;14(5):959-965.[3]. Practical Notes for teLuc-DTZ a
溶解度数据
In Vitro: DMSO : 100 mg/mL (264.94 mM; Need ultrasonic; DMSO can inactivate Diphenylterazines activity)DMF : 11.11 mg/mL (29.44 mM; Need ultrasonic; DMSO can inactivate Diphenylterazines activity)EtOH+HCl : 1 mg/mL (2.65 mM; ultrasonic and warming and adjust pH to 2 with 1M HCl and heat to 80°C; DMSO can inactivate Diphenylterazines activity)H2O : < 0.1 mg/mL (insoluble